Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

1.6K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.6K
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

804
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
804
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

143
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
143

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modification effect of multiple gestation on the relationship between maternal body mass index and miscarriage in frozen-thawed embryo transfer: a retrospective cohort study.

Reproductive biology and endocrinology : RB&E·2026
Same author

Approaches for Detecting Protein <i>S</i>-Palmitoylation and Depalmitoylation.

Critical reviews in analytical chemistry·2026
Same author

Early glycaemic exposure and cancer risk in people with newly diagnosed type 2 diabetes.

Diabetologia·2026
Same author

Peripheral immunosenescence biomarkers and longitudinal cognitive decline: a large population-based study.

npj aging·2026
Same author

Author's Reply: Letter to the Editor: Concerns Regarding Folic Acid in the Prevention and Treatment of Cervical Cancer.

Nutrition reviews·2026
Same author

Prognostic value of FNA-Tg for local recurrence following lateral neck dissection in papillary thyroid carcinoma.

BMC endocrine disorders·2026

相关实验视频

Updated: May 3, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

932

一个用于甲状腺细分和剂量评估的多尺度网络,用于高甲状腺患者的不确定性量化.

Chao Wang1, Guang Hu1, Fu Ji1

  • 1Department of Nuclear Science and Technology, Xi'an Jiaotong University, Xi'an, China.

Medical physics
|October 22, 2025
PubMed
概括

这项研究开发了一种深度学习模型,用于使用医学内部辐射剂量 (MIRD) 方案准确计算甲状腺吸收剂量,用于治疗甲状腺功能障碍. 该模型提高了细分的准确性,并量化了不确定性,改善了个性化剂量计.

关键词:
在MSRA-UNet++中使用.蒙特卡罗的蒙特卡罗是一个非常好的城市.吸收的剂量吸收的剂量甲状腺功能过强症 甲状腺功能过强症图像细分 图像细分这就是Voxel Phantoms.

更多相关视频

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
04:23

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

Published on: April 21, 2023

2.3K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.0K

相关实验视频

Last Updated: May 3, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

932
A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
04:23

A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images

Published on: April 21, 2023

2.3K
Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis
05:41

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

1.0K

科学领域:

  • 医学物理 医学物理
  • 辐射科学 辐射科学
  • 人工智能在医学中的应用

背景情况:

  • 精确的吸收剂量评估对于使用放射性 (131I) 进行个性化甲状腺功能障碍治疗至关重要.
  • 使用医学内部辐射剂量 (MIRD) 方案计算甲状腺剂量存在挑战,特别是在图像细分和不确定性量化方面.
  • 从MIRD和马里内利-奎姆比公式对剂量估计进行比较需要进一步调查.

研究的目的:

  • 设计一个基于MIRD模式的多尺度深度学习模型,以提高对高甲状腺患者的吸收剂量计算的准确性和可靠性.
  • 为了改进剂量计,将不确定性量化纳入细分过程.
  • 为了比较MIRD方案和马里内利-奎姆比公式之间的吸收剂量估计值.

主要方法:

  • 开发了一个UNet++架构,包含多个尺度的剩余和多头注意模块 (MSRA-UNet++).
  • 实施了基于信息的不确定性量化模块,用于细分信心评估.
  • 创建了针对患者的甲状腺voxel幻影,使用蒙特卡洛方法计算S值,并使用MIRD图表评估吸收剂量.

主要成果:

  • MSRA-UNet++模型在多器官细分方面实现了高性能,子相似系数 (DSC) 为88.23%和豪斯多夫距离95% (HD95) 为9.43像素,用于甲状腺细分.
  • 雅卡德指数 (JI) 在临床数据集上与UNet++相比提高了6.17%,在甲状腺边缘量化不确定性.
  • 马里内利-奎姆比公式高估了MIRD方案的吸收剂量,平均为7.74%.

结论:

  • 该MSRA-UNet++网络提供精确的甲状腺细分与估计的不确定性,通过组合的细分不确定性和蒙特卡洛模拟提高S值的可靠性.
  • 这项研究是首次将不确定性量化纳入甲状腺功能过高患者的CT图像细分,利用患者特定的幻影和放射性动力学进行基于MIRD的剂量评估.
  • 代码将在GitHub上发布,以促进进一步的研究和应用.